ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 529469 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 529469; 2) Community: the network communities that were significantly associated with the response to NSC 529469; 3) Molecule: the relationships between components within communities and NSC 529469; 4) MDR: the compounds that were significantly associated with the NSC 529469.

NSC Compound Enrichment Correlation
NSC 67586 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, 0.017498903403062 -0.45877523
NSC 759178 Pipamperone 0.017498903403062 -0.010099618
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.017498903403062 0.049013121
NSC 274553 Null 0.0174989034030623 -0.30194583
NSC 5159 X 465A 0.0174989034030623 0.11092833
NSC 617668 DOLASTATIN 15 0.0178844438004194 -0.085282192
NSC 694269 Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate 0.0178844438004194 0.19082275
NSC 717532 Null 0.0178844438004194 0.096667744
NSC 745455 Null 0.0178844438004194 0.11350168
NSC 343499 CI-921: amsacrine derivative 0.0178844438004195 0.22607489
Total:40  Current:11    [First] [Prev] [Next] [Last]